概述

  • 产品名称Anti-B4GALT3抗体
    参阅全部 B4GALT3 一抗
  • 描述
    兔多克隆抗体to B4GALT3
  • 特异性ab74825 detects endogenous levels of total B4GALT3 protein.
  • 经测试应用适用于: WB, ELISA, IHC-Pmore details
  • 种属反应性
    与反应: Human
    预测可用于: Mouse, Rat
  • 免疫原

    Synthesized peptide derived from an internal region of human B4GALT3

  • 阳性对照
    • WB: extracts from HepG2 cells, HeLa cells and Jurkat cells IHC-P: human liver carcinoma tissue

性能

应用

Our Abpromise guarantee covers the use of ab74825 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB 1/500 - 1/1000. Predicted molecular weight: 44 kDa.
ELISA 1/40000.
IHC-P Use at an assay dependent concentration.

靶标

Anti-B4GALT3 antibody 图像

  • All lanes : Anti-B4GALT3 antibody (ab74825) at 1/500 dilution

    Lane 1 : extracts from HepG2 cells
    Lane 2 : extracts from HeLa cells
    Lane 3 : extracts from Jurkat cells
    Lane 4 : extracts from Jurkat cells with immunizing peptide at 10 µg

    Lysates/proteins at 30 µg per lane.


    Predicted band size : 44 kDa
    Observed band size : 44 kDa
  • ab74825, at a dilution of 1/50, staining B4GALT3 in paraffin embedded human liver carcinoma tissue sections by Immunohistochemistry in the absence (left image) or presence (right image) of the immunizing peptide.

Anti-B4GALT3 antibody (ab74825)参考文献

This product has been referenced in:
  • Zhou H  et al. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1. Cell Death Dis 4:e654 (2013). WB ; Human . Read more (PubMed: 23744354) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab74825.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"